TherapeuticsMD Inc.
Last updated September 27, 2026
Organization details
- Legal name
- TherapeuticsMD Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- TXMD
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000025743
Board of directors
-
Cooper C. Collins · DirectorSince 2023
-
David Efraim Rosen · DirectorSince 2023
-
Gail K. Naughton · DirectorSince 2023
-
Tommy G. Thompson · DirectorSince 2023
Board connections
2 of this board's directors also sit on 4 other boards.
- via Gail K. Naughton
- via Tommy G. Thompson
- via Tommy G. Thompson
- via Tommy G. Thompson
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $14,028
- 1 purchase by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 23, 2025 | Tommy G. Thompson Director | Open-market purchase | +8,400 | $1.67 | $14,028 |
| Apr 14, 2025 | Tommy G. Thompson Director | Open-market purchase | +325 | $1.00 | $325 |
| Apr 14, 2025 | Walker Marlan D Officer (Chief Executive Officer) | Open-market purchase | +490 | $1.00 | $490 |
| Apr 10, 2025 | Walker Marlan D Officer (Chief Executive Officer) | Open-market purchase | +1,167 | $0.86 | $1,004 |
| Apr 9, 2025 | Walker Marlan D Officer (Chief Executive Officer) | Open-market purchase | +1,136 | $0.87 | $988 |
| Feb 18, 2025 | Cooper C. Collins Director | Option exercise | +8,500 | — | — |
| Feb 18, 2025 | Gail K. Naughton Director | Option exercise | +8,500 | — | — |
| Feb 18, 2025 | Tommy G. Thompson Director | Option exercise | +8,500 | — | — |
| Feb 18, 2025 | Walker Marlan D Officer (Chief Executive Officer) | Option exercise | +3,467 | — | — |
| Feb 18, 2025 | Walker Marlan D Officer (Chief Executive Officer) | Option exercise | +2,311 | — | — |
| Feb 18, 2025 | Walker Marlan D Officer (Chief Executive Officer) | Option exercise | +770 | — | — |
| Feb 18, 2025 | Walker Marlan D Officer (Chief Executive Officer) | Option exercise | +1,733 | — | — |
| Aug 22, 2024 | Cooper C. Collins Director | Open-market purchase | +4,094 | $1.73 | $7,083 |
| Aug 21, 2024 | Cooper C. Collins Director | Open-market purchase | +1,200 | $1.70 | $2,040 |
| Dec 7, 2023 | Walker Marlan D Officer (Chief Executive Officer) | Open-market sale | −4,550 | $2.24 | $10,192 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.